Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda Ewart Toland

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Journal of Neurophysiology|January 27, 2021
Machine learning approaches reveal subtle differences in breathing and sleep fragmentation in <i>Phox2b</i>-derived astrocytes ablated miceTalita M Silva, Jeremy C Borniger, Michele Joana Alves, et al.
Nature Genetics|July 26, 2003
Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and humanAmanda Ewart-Toland, Paraskevi Briassouli, John P de Koning, et al.
Breast Cancer Research and Treatment|March 14, 2022
Differences in somatic TP53 mutation type in breast tumors by race and receptor statusNijole C Pollock, Johnny R Ramroop, Heather Hampel, et al.
Cancer|December 2, 2016
Differential mutation frequencies in metastatic cutaneous squamous cell carcinomas versus primary tumorsAyse Selen Yilmaz, Hatice Gulcin Ozer, Jessica L Gillespie, et al.
Journal of Personalized Medicine|June 14, 2014
Design and implementation of a randomized controlled trial of genomic counseling for patients with chronic diseaseKevin Sweet, Erynn S Gordon, Amy C Sturm, et al.
NPJ Genomic Medicine|February 27, 2018
Clinical testing of <i>BRCA1</i> and <i>BRCA2</i>: a worldwide snapshot of technological practicesAmanda Ewart Toland, Andrea Forman, Fergus J Couch, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 24, 2026
The Clinical Application of Refined Risk Estimates (caRe) Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled TrialLeigha Senter, Shelly Hovick, Rachel Notestine, et al.
Carcinogenesis|April 2, 2005
Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer typesAmanda Ewart-Toland, Qi Dai, Yu-Tang Gao, et al.
Journal of the National Cancer Institute|August 13, 2018
Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel TestingHermela Shimelis, Holly LaDuca, Chunling Hu, et al.
Medrxiv : the Preprint Server for Health Sciences|December 18, 2023
Association of <i>ESR1</i> germline variants with <i>TP53</i> somatic variants in breast tumors in a genome-wide studyNijole P Tjader, Abigail J Beer, Johnny Ramroop, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Journal of Neurophysiology|January 27, 2021
Machine learning approaches reveal subtle differences in breathing and sleep fragmentation in <i>Phox2b</i>-derived astrocytes ablated miceTalita M Silva, Jeremy C Borniger, Michele Joana Alves, et al.
Nature Genetics|July 26, 2003
Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and humanAmanda Ewart-Toland, Paraskevi Briassouli, John P de Koning, et al.
Breast Cancer Research and Treatment|March 14, 2022
Differences in somatic TP53 mutation type in breast tumors by race and receptor statusNijole C Pollock, Johnny R Ramroop, Heather Hampel, et al.
Cancer|December 2, 2016
Differential mutation frequencies in metastatic cutaneous squamous cell carcinomas versus primary tumorsAyse Selen Yilmaz, Hatice Gulcin Ozer, Jessica L Gillespie, et al.
Journal of Personalized Medicine|June 14, 2014
Design and implementation of a randomized controlled trial of genomic counseling for patients with chronic diseaseKevin Sweet, Erynn S Gordon, Amy C Sturm, et al.
NPJ Genomic Medicine|February 27, 2018
Clinical testing of <i>BRCA1</i> and <i>BRCA2</i>: a worldwide snapshot of technological practicesAmanda Ewart Toland, Andrea Forman, Fergus J Couch, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 24, 2026
The Clinical Application of Refined Risk Estimates (caRe) Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled TrialLeigha Senter, Shelly Hovick, Rachel Notestine, et al.
Carcinogenesis|April 2, 2005
Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer typesAmanda Ewart-Toland, Qi Dai, Yu-Tang Gao, et al.
Journal of the National Cancer Institute|August 13, 2018
Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel TestingHermela Shimelis, Holly LaDuca, Chunling Hu, et al.
Medrxiv : the Preprint Server for Health Sciences|December 18, 2023
Association of <i>ESR1</i> germline variants with <i>TP53</i> somatic variants in breast tumors in a genome-wide studyNijole P Tjader, Abigail J Beer, Johnny Ramroop, et al.
Pageof 8